News

The approval of Apidra for pediatric use is based upon FDA review of a 26-week, Phase III, open-label, active control study of Apidra in comparison with insulin lispro,

The goal of the partnership is to provide an end-to-end solution for DNA analysis that is truly fast, affordable and user friendly. The basis of the collaboration is

The company will initiate clinical trials in November 2008 to evaluate this drug, a third generation Cephalosporin antibiotic combined with a bacterial-enzyme inhibitor, for the treatment of infections.

With the FDA investigational device exemption (IDE) approval in place, Dune is launching a nationwide US clinical trial of MarginProbe, which uses radio frequency spectroscopy to characterize breast

Data from two long-term, open-label extension studies has showed that Enbrel provided improvement in the signs and symptoms of rheumatoid arthritis (RA) that was maintained for up to

In its final guidance, the National Institute for Health and Clinical Excellence (NICE) has confirmed that spinal cord stimulation (SCS) is both safe and clinically effective in these

According to the company, the Curos Port Protector is designed to reduce patient exposure to the risks of hospital acquired bloodstream infections and help maintain hospital infection control

The patents for the company’s Skinfusion technology cover the intermediate formulation during manufacturing and the finished product for a transdermal patch containing estrogen and progestin used in contraception.

Bristol-Myers Squibb collaborates with ImClone on Erbitux in North America and is making the product commercially available through its wholly-owned subsidiary Bristol-Myers Squibb Canada. Erbitux is approved by